Omega 3: Should we indicate it in our patients?

Authors

  • Marta Milikowski Argentine Society of Diabetes, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.550

Keywords:

omega 3, benefits

Abstract

Lipids are identified as a fundamental component of the diet because they perform very important functions.

They influence the modulation of immune functions and inflammatory processes; attributable to long-chain polyunsaturated fatty acids (long chain polyunsaturated fatty acids (LCPUFA).

Author Biography

Marta Milikowski, Argentine Society of Diabetes, Autonomous City of Buenos Aires, Argentina

Medical consultant Nutrition Service, Hospital C. Durand, specialist in Gastroenterology and Medical, University specialist in Nutrition

References

-

Downloads

Published

2022-09-01

How to Cite

Milikowski, M. (2022). Omega 3: Should we indicate it in our patients?. Journal of the Argentine Society of Diabetes, 56(3Sup), 53–53. https://doi.org/10.47196/diab.v56i3Sup.550

Issue

Vol. 56 No. 3Sup (2022): September/December 2022

Section

6 voices in 10 minutes part 1

License

Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.